Pan-cancer analysis and KNSTRN as a potential prognosis biomarker

被引：0
|
作者：
Xiao, Shanshan [1 ]
Zou, Yuqing [1 ]
Wang, Li [1 ]
Wang, Qian [1 ]
Wang, Tao [1 ]
机构：
[1] Hangzhou Repugene Technol Co Ltd, Hangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15180
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
    Yuan, Ziming
    Zhong, Yuchen
    Hu, Hanqing
    Zhang, Weiyuan
    Wang, Guiyu
    [J]. FRONTIERS IN ONCOLOGY, 2023, 12
  • [2] Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
    Yumei Tang
    Ye Lei
    Peng Gao
    Junting Jia
    Huijun Du
    Qitong Wang
    Zhixin Yan
    Chen Zhang
    Guojun Liang
    Yanfeng Wang
    Weijun Ma
    Nianzeng Xing
    Le Cheng
    Laifeng Ren
    [J]. BMC Cancer, 23
  • [3] Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
    Tang, Yumei
    Lei, Ye
    Gao, Peng
    Jia, Junting
    Du, Huijun
    Wang, Qitong
    Yan, Zhixin
    Zhang, Chen
    Liang, Guojun
    Wang, Yanfeng
    Ma, Weijun
    Xing, Nianzeng
    Cheng, Le
    Ren, Laifeng
    [J]. BMC CANCER, 2023, 23 (01)
  • [4] A pan-cancer analysis of ABI3BP: a potential biomarker for prognosis and immunoinfiltration
    Feng, Yan
    Tao, Fengying
    Qiao, Han
    Tang, Huaping
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
    Hu, Jian
    Qiu, Dongxu
    Yu, Anze
    Hu, Jiao
    Deng, Hao
    Li, Huihuang
    Yi, Zhenglin
    Chen, Jinbo
    Zu, Xiongbing
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis
    Ning, Yijie
    Li, Yufei
    Wang, Hongqin
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [7] Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
    Zhang, Jing
    Wang, Kai
    Hainisayimu, Tuersun
    Li, Hui
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [8] CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer
    Lu, Ke-Qi
    Li, Zuo-Lin
    Zhang, Qian
    Yin, Qing
    Zhang, Yi-Lin
    Ni, Wei-Jie
    Jiang, LiangYun-Zi
    He, Wei
    Wang, Bin
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
    Cai, Jiayang
    Ye, Zhang
    Hu, Yuanyuan
    Wang, Yixuan
    Ye, Liguo
    Gao, Lun
    Sun, Qian
    Tong, Shiao
    Sun, Zhiqiang
    Yang, Ji'an
    Chen, Qianxue
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
    Zhou, Bolun
    Gao, Shugeng
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
12345